Get the Stockscreener App
38.43
6.03%
-2.465
After Hours:
38.34
-0.09
-0.23%
Bruker Corp stock is traded at $38.43, with a volume of 2.99M.
It is down -6.03% in the last 24 hours and down -6.72% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$40.90
Open:
$40.345
24h Volume:
2.99M
Relative Volume:
1.13
Market Cap:
$5.82B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
18.48
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
-4.99%
1M Performance:
-6.72%
6M Performance:
-33.91%
1Y Performance:
-43.91%
1-Day Range:
$38.31
$41.49
1-Week Range:
$38.31
$44.36
52-Week Range:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
38.43 | 6.20B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
What catalysts could drive Bruker Corporation stock higher in 2025Achieve rapid portfolio growth with expert help - jammulinksnews.com
Is Bruker Corporation a growth stock or a value stockGet real-time alerts on high-potential stocks - jammulinksnews.com
When is Bruker Corporation stock expected to show significant growthHigh-octane investment opportunities await - jammulinksnews.com
How strong is Bruker Corporation company’s balance sheetUnlock daily stock market insights for success - jammulinksnews.com
Why Bruker Corporation stock attracts strong analyst attentionHigh Win Rate Stock Ideas - metal.it
Should You Investigate Bruker Corporation (NASDAQ:BRKR) At US$41.94? - 富途牛牛
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $46 to $50 - 富途牛牛
Is Bruker Corporation stock a growth or value playDouble-digit growth - jammulinksnews.com
Is Bruker Corporation a good long term investmentConsistent triple returns - jammulinksnews.com
Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment - MSN
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Bruker First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
S&P 500 eyes new record, Opendoor skyrockets, Bruker plummets - Yahoo Finance
Wall Street Extends Records, Gold Rallies To $3,400: What's Moving Markets Monday? - Benzinga
Why Bruker (BRKR) Shares Are Getting Obliterated Today - Yahoo Finance
Bruker Projects Q2 Revenue Of $795M–$798M; Non-GAAP EPS Expected At $0.32–$0.34, Down $0.19 YoY Amid $0.06 FX Impact - 富途牛牛
Bruker stock plunges as Stifel maintains Hold rating amid Q2 revenue miss - Investing.com Canada
Bruker Visibility, Credibility in Focus After Preliminary 2Q Results -- Market Talk - 富途牛牛
Bruker tumbles as preliminary Q2 results show revenue decline By Investing.com - Investing.com Canada
Bruker tumbles as preliminary Q2 results show revenue decline - Investing.com
Press Release: Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - 富途牛牛
Bruker Q2 Earnings Show $798M Revenue as Biopharma Weakness, Academic Slowdown Impact Results - Stock Titan
What analysts say about Bruker Corporation stockSkyrocketing returns - PrintWeekIndia
What drives Bruker Corporation stock priceDouble-digit growth - jammulinksnews.com
Bruker Corporation Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
Bruker Corp's shares drop 3.89% on July 18 - AInvest
10x Genomics Ends UPC Patent Fight With Bruker - Law360
March 2026 Options Now Available For Bruker (BRKR) - Nasdaq
How Bruker Corporation stock performs during market volatilityFree Discussion Group - beatles.ru
Rare Earth Metals concept stocks continued to rise at the start of the day, as the United States aims to accelerate the construction of the Rare Earth Metals supply chain, and the Bruker Corp Rare Earth Metals project in Wyoming has officially launched. - 富途牛牛
Bruker Corp Shares Surge 3.51% Amid Analyst Estimates and GF Value Prediction - AInvest
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Acquires Majority Stake in RECIPE, Boosts Diagnostic and Drug Monitoring Capabilities - Yahoo Finance
Bruker: Weakness In Academic Research Shadows Near-Term Growth; Initiate With 'Hold' - Seeking Alpha
Bruker price target lowered to $50 from $61 at BofA - Yahoo Finance
BRKR: B of A Securities Updates Price Target for Bruker | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by BofA Amid Market Uncertain - GuruFocus
A Glimpse Into The Expert Outlook On Bruker Through 9 Analysts - Benzinga
AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology - Insider Monkey
Bruker Secures Massive 27-System Order as AI Chip Demand Drives Advanced Packaging Growth - Stock Titan
10x Genomics Settles Patent Dispute With Bruker. - Yahoo Finance
10x Genomics Settles Patent Dispute With Bruker - Yahoo.co
First Week of August 15th Options Trading For Bruker (BRKR) - Nasdaq
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):